There is a significant market for new, selective, non-narcotic compounds to treat pain.
The global pain management therapeutics market was valued at approximately USD $72.4 million in 2021. Market research anticipates that its value will expand to nearly $106 billion by 2030.11
In the United States alone, the pain management therapeutics market is projected to reach over $12.5 billion by 2028.12 A recent study indicates that the global acetaminophen market, valued at $9.4 billion in 2021, will grow to over $14.1 billion by 2031.13
South Rampart Pharma’s solution is a novel small molecule, introducing a value product that will be low cost and accessible to many patients.